Home
Debasis Nandy Board Membership
About Debasis Nandy
- Debasis Nandy was appointed as an Independent Director of Jagsonpal Pharmaceuticals Ltd on June 29, 2022, and his appointment was confirmed at the Annual General Meeting held on September 14, 2022.
- He serves on the Board alongside other industry experts and chairs the Audit Committee, contributing his extensive experience and expertise in finance and corporate governance to the company.
List of Companies Associated with Debasis Nandy
| Company Name |  Position Held |
|---|---|
| Jagsonpal Pharmaceuticals Ltd | Independent Director |
Historical Share Prices
Debasis Nandy Sector Specific Experience
About Debasis Nandy's Work Experience
- Debasis Nandy is currently a Independent Director in Jagsonpal Pharmaceuticals Ltd (as of Mar 2024).
- Debasis Nandy is serving the company - Jagsonpal Pharmaceuticals Ltd at this position since 2023 for the last 3+ years.
- Debasis Nandy was Independent Director of Jagsonpal Pharmaceuticals Ltd for 3 years from 2022 to 2024.
FAQ's related Debasis Nandy
Who is Debasis Nandy
Debasis Nandy was appointed as an Independent Director of Jagsonpal Pharmaceuticals Ltd on June 29, 2022, and his appointment was confirmed at the Annual General Meeting held on September 14, 2022. He serves on the Board alongside other industry experts and chairs the Audit Committee, contributing his extensive experience and expertise in finance and corporate governance to the company.
Which companies does Debasis Nandy serve as a board member for?
Debasis Nandy serves as a board member for: Jagsonpal Pharmaceuticals Ltd
What positions has Debasis Nandy held in his/her career?
Throughout their career, Debasis Nandy has held key positions such as Independent Director, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
